GL1X · GenesisL1 explorer

UniProt P43220

Glucagon-like peptide 1 receptor (P43220)

Glucagon-like peptide 1 receptor (UniProt P43220), EC 3.2.1.17: 73 experimental structures and 1 predicted model on GenesisL1, 26 ligands bound, 100 pockets. Binding sites, druggability and experiment against prediction…

UniProt
P43220
Protein
Glucagon-like peptide 1 receptor
EC
3.2.1.17
Experimental structures
73
Predicted models
1
Ligands
26
Pockets
100 · 14 records with a druggable one

Structures

74 records of P43220 in the MolNFT archive: 73 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
3C59Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domainx-ray diffractionA——
3C59Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domainx-ray diffractionA——
3C5TCrystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domainx-ray diffractionA——
3C5TCrystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domainx-ray diffractionA——
3IOLCrystal structure of Glucagon-Like Peptide-1 in complex with the extracellular domain of the…x-ray diffractionA——
3IOLCrystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the…x-ray diffractionA——
4ZGMCrystal structure of Semaglutide peptide backbone in complex with the GLP-1 receptor extracellular…x-ray diffractionA32M—
4ZGMCrystal structure of semaglutide peptide backbone in complex with the glp-1 receptor extracellular…x-ray diffractionA——
5E94Antibody-bound Glucagon-like Peptide-1 receptor extracellular domainx-ray diffractionG, H—4 (best 0.37)
5E94Antibody-bound glucagon-like peptide-1 receptor extracellular domainx-ray diffractionG, H——
5NX2Crystal structure of thermostabilised full-length GLP-1R in complex with a truncated peptide…x-ray diffractionANAG, SOG3 (best 0.82)
5NX2Crystal structure of thermostabilised full-length glp-1R in complex with a truncated peptide…x-ray diffractionA9DK, 9DQ, 9DT, 9DW, 9DZ, NAG—
5OTTExtracellular domain of GLP-1 receptor in complex with exendin-4 variant Gly2Hcs/Thr5Hcsx-ray diffractionA——
5OTTExtracellular domain of glp-1 receptor in complex with exendin-4 variant GLY2HCS/THR5HCSx-ray diffractionA——
5OTUExtracellular domain of GLP-1 receptor in complex with GLP-1 variant Ala8Hcs/Thr11Hcsx-ray diffractionA, C—1 (best 0.67)
5OTUExtracellular domain of glp-1 receptor in complex with glp-1 variant ALA8HCS/THR11HCSx-ray diffractionA, C——
5OTVExtracellular domain of glp-1 receptor in complex with glp-1 variant ALA8CYC/THR11HCSx-ray diffractionC, A——
5OTWExtracellular domain of glp-1 receptor in complex with glp-1 variant ALA8HCS/THR11CYSx-ray diffractionC, A——
5OTXExtracellular domain of GLP-1 receptor in complex with GLP-1 variant Ala8Cys/Thr11Cysx-ray diffractionA, C—4 (best 0.48)
5OTXExtracellular domain of glp-1 receptor in complex with glp-1 variant ALA8CYS/THR11CYSx-ray diffractionA, C——
5VEWStructure of the human GLP-1 receptor complex with PF-06372222x-ray diffractionA, B97Y, OLA13 (best 0.69)
5VEWStructure of the human glp-1 receptor complex with pf-06372222x-ray diffractionA, B97Y, OLA—
5VEXStructure of the human GLP-1 receptor complex with NNC0640x-ray diffractionA, B97V14 (best 0.70)
5VEXStructure of the human glp-1 receptor complex with NNC0640x-ray diffractionA, B97V—
6B3J3.3 ångström phase-plate cryo-EM structure of a biased agonist-bound human glp-1 receptor-gs complexelectron microscopyR——
6GB1Crystal structure of the GLP1 receptor ECD with Peptide 11x-ray diffractionASO4—
6GB1Crystal structure of the GLP1 receptor ecd with peptide 11x-ray diffractionANH2, SO4—
6KJVStructure of thermal-STABILISED(M9) human glp-1 receptor transmembrane domainx-ray diffractionA, B97Y—
6KK1Structure of thermal-stabilised(M8) human GLP-1 receptor transmembrane domainx-ray diffractionA, B97Y—
6KK1Structure of thermal-STABILISED(M8) human glp-1 receptor transmembrane domainx-ray diffractionA, B97Y—
6KK7Structure of thermal-STABILISED(M6) human glp-1 receptor transmembrane domainx-ray diffractionA, B97Y—
6LN2Crystal structure of full length human GLP1 receptor in complex with Fab fragment (FAB7F38)x-ray diffractionANAG, ZN, 97Y—
6ORVNon-peptide agonist (TT-OAD2) bound to the Glucagon-Like peptide-1 (GLP-1) Receptorelectron microscopyRPN2V6 (best 0.76)
6VCBCryo-EM structure of the glucagon-like peptide-1 receptor in complex with G protein, glp-1 peptide…electron microscopyRQW7—
6X18Glp-1 peptide hormone bound to glucagon-like peptide-1 (glp-1) receptorelectron microscopyR——
6X19Non peptide agonist chu-128, bound to glucagon-like peptide-1 (glp-1) receptorelectron microscopyRUK1—
6X1ANon peptide agonist PF-06882961, bound to Glucagon-Like peptide-1 (GLP-1) Receptorelectron microscopyRUK46 (best 0.85)
6X1ANon peptide agonist pf-06882961, bound to glucagon-like peptide-1 (glp-1) receptorelectron microscopyRUK4—
6XOXcryo-EM of human GLP-1R bound to non-peptide agonist LY3502970electron microscopyRV6G6 (best 0.79)
6XOXCryo-EM of human glp-1R bound to non-peptide agonist LY3502970electron microscopyRV6G—
7C2EGlp-1R-gs complex structure with a small molecule full agonistelectron microscopyRFFR—
7DUQCryo-EM structure of the compound 2 and glp-1-bound human glp-1 receptor-gs complexelectron microscopyRHNO, CLR—
7DURCryo-EM structure of the compound 2-bound human glp-1 receptor-gs complexelectron microscopyRHNO, CLR—
7E14Compound2_GLP-1R_OWL833_Gs complex structureelectron microscopyRV6G, CLR, HNO—
7E14COMPOUND2_GLP-1R_OWL833_GS complex structureelectron microscopyRV6G, CLR, HNO—
7EVMCryo-EM structure of the compound 2-bound human GLP-1 receptor-Gs complexelectron microscopyRHNO, CLR—
7EVMCryo-EM structure of the compound 2-bound human glp-1 receptor-gs complexelectron microscopyRHNO, CLR—
7FIMCryo-EM structure of the tirzepatide (LY3298176)-bound human glp-1R-gs complexelectron microscopyR——
7KI0Semaglutide-bound glucagon-like peptide-1 (glp-1) receptor in complex with gs proteinelectron microscopyR——
7KI1Taspoglutide-bound glucagon-like peptide-1 (glp-1) receptor in complex with gs proteinelectron microscopyR——
7LCIPF 06882961 bound to the glucagon-like peptide-1 receptor (GLP-1R):Gs complexelectron microscopyRUK4—
7LCIPf 06882961 bound to the glucagon-like peptide-1 receptor (glp-1R):GS complexelectron microscopyRUK4—
7LCJPF 06882961 bound to the glucagon-like peptide-1 receptor (GLP-1R):Gs complexelectron microscopyRUK43 (best 0.85)
7LCJPf 06882961 bound to the glucagon-like peptide-1 receptor (glp-1R):GS complexelectron microscopyRUK4—
7LCKPf 06882961 bound to the glucagon-like peptide-1 receptor (glp-1R)electron microscopyRUK4—
7LLLExendin-4-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in complex with Gs proteinelectron microscopyR—9 (best 0.74)
7LLLExendin-4-bound glucagon-like peptide-1 (glp-1) receptor in complex with gs proteinelectron microscopyR——
7LLYOxyntomodulin-bound glucagon-like peptide-1 (glp-1) receptor in complex with gs proteinelectron microscopyR——
7RG9Cryo-EM of human glucagon-like peptide 1 receptor glp-1R in apo formelectron microscopyR——
7RGPCryo-EM of human glucagon-like peptide 1 receptor glp-1R bound to tirzepatideelectron microscopyR——

14 records more on the page itself.

Ligands

  • 97Y · N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine · in 7 records
  • UK4 · 2-[(4-{6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2S)-oxetan-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid · in 7 records
  • CLR · Cholesterol · in 6 records
  • HNO · N-tert-butyl-6,7-bis(chloranyl)quinoxalin-2-amine · in 6 records
  • V6G · 3-[(1S,2S)-1-(5-[(4S)-2,2-dimethyloxan-4-yl]-2-{(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carbonyl}-1H-indol-1-yl)-2-methylcyclopropyl]-1,2,4-oxadiazol-5(4H)-one · in 4 records
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 3 records
  • 97V · 4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl) phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl) benzamide · in 2 records
  • D6M · N-hexadecanoyl-L-glutamic acid · in 2 records
  • OLA · Oleic acid · in 2 records
  • SO4 · Sulfate ion · in 2 records
  • SOG · octyl 1-thio-beta-D-glucopyranoside · in 2 records
  • WB2 · 2,4-bis(3-methoxy-4-thiophen-2-ylcarbonyloxy-phenyl)-1, 3-bis[[4-(2-methylpropanoylamino) phenyl]carbonylamino]cyclobutane-1,3-dicarboxylic acid · in 2 records
  • 32M · 3,6,9,12,15,18-hexaoxahexacosan-1-ol · in 1 record
  • 82L · 2-[(4-{6-[(2,4-difluorophenyl)methoxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid · in 1 record
  • 9DK · 3-[2-(1~{H}-imidazol-4-yl)ethylamino]-2,2-dimethyl-3-oxidanylidene-propanoic acid · in 1 record
  • 9DQ · (2~{S})-2-azanyl-3-(1~{H}-1,2,3,4-tetrazol-5-yl) propanoic acid · in 1 record
  • 9DT · (2~{S})-2-azanyl-3-(2-fluorophenyl)-2-methyl-propanoic acid · in 1 record
  • 9DW · (2~{S})-2-azanyl-3-[4-(2-ethyl-4-methoxy-phenyl) phenyl]propanoic acid · in 1 record
  • 9DZ · (2~{S})-2-azanyl-5-(3,5-dimethylphenyl)pentanamide · in 1 record
  • BYI · 2,4-bis(3-methoxy-4-thiophen-2-ylcarbonyloxy-phenyl)-1, 3-bis[[4-[(2-methylpropan-2-yl) oxycarbonylamino]phenyl]carbonylamino]cyclobutane-1,3-dicarboxylic acid · in 1 record
  • FFR · 2-[[4-[6-[(4-cyano-2-fluoranyl-phenyl)methoxy]pyridin-2-yl]-3,6-dihydro-2~{H}-pyridin-1-yl]methyl]-3-[[(2~{S})-oxetan-2-yl]methyl]imidazo[4,5-b]pyridine-5-carboxylic acid · in 1 record
  • N2V · N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine · in 1 record
  • NH2 · Amino group · in 1 record
  • QW7 · 1-[(1R)-1-(2,6-dichloro-3-methoxyphenyl)ethyl]-6-{2-[(2R)-piperidin-2-yl]phenyl}-1H-benzimidazole · in 1 record
  • UK1 · 3-{(1S)-1-[5-(2,2-dimethylmorpholin-4-yl)-2-{(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl]-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carbonyl}-1H-indol-1-yl]butyl}-1,2,4-oxadiazol-5(4H)-one · in 1 record
  • ZN · Zinc ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.